Now, there are many companies that outsource all or part of their pre-clinical and clinical research to Contract Research Organizations CROs. As a result, CROs are becoming an integral part of pharma and device product development value creation. Given the complex regulatory landscape of the bioscience industry, the selection of a CRO should be made carefully as it impacts the prospects of getting favorable FDA outcomes. Identifying the best-fit CRO involves a variety of processes and people. This event will help small and mid-size biotech and MedTech companies tackle the following issues:
This meeting will feature the following speakers:
Agenda
10:00 am
Welcoming Remarks and Introduction by Ahmed Enany, President & CEO, SoCalBio
10:10 am
“Harnessing Today’s Innovations: Introducing Scientists.com, A Marketplace for
Outsourced Scientific Services”
Presentation by Arne Brandon, Chief Commercial Office, Scientist.com
10:40 am
“Keep Your Eye on the Price: Using a commercial lens to optimize clinical development”
Presentation by Michael Davitian, Director, Market Access Group, Parexel International:
11:10 am
“Making Research Easy”
Presentation by Michael Lau, Ph.D. Regional Sales Manager, GenScripts
11:40 am
“Achieving Success in Developing Clinical Candidates”
Presentation by Marcus Wagstaff, BSc, Associate Business Development Director – Discovery Services, Kristin Power, MSc, Business Development Director – Safety Assessment & Srna Vlaho, BSc, Business Innovation Manager – Research Models and Services, Charles River Laboratories
12:10 pm
Break and Luncheon
1:00 pm
“Phase 1 CROs: Guiding You Through Partnering in Early Clinical Development”
Presentation by Robina M. Smith, MD, Medical Director, WCCT
1:30 pm
“Navigate the Medical Device Development Process with a Proven Regulatory and Clinical Strategy that Works”
Presentation by “David R. Dills, Director, and Head of Regulatory Affairs, CROMSOURCE
2:00 pm
“Digital Solutions to Facilitate Clinical Research”
Presentation by Science 37
2:30 pm
“The Difficult Decision – Identifying What’s Important for CDMO Selection”
Presentation by Mike Faughnan, Director, Business Development,
3:00 pm
“Concluding Remarks,” by Ahmed Enany, President & CEO, SoCalBio
3:15 pm
Meeting Adjourns
Have questions about SoCalBio Mini Conference: Working with the Best Clinical Research Organizations (CROs)? Contact Southern California Biomedical Council